Skip to content
RDL Network logo
843-6 Three-year follow-up of the RAVEL study: A randomized study with the sirolimus-elutin gBx VELOCITY™ stent in the treatment of patients with de novo native coronary artery lesions — Marie‐Claude Morice (2004) | RDL Network